Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)	Chronobiology Disorders, Disorders of Excessive Somnolence, Dyssomnias, Occupational Diseases, Sleep Disorders, Intrinsic, circadian rhythm sleep disorder, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorder	Recruiting	Phase 3	2026-07-24		NCT06568367

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Axsome Therapeutics, Inc.	14

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials